BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Lumicell Granted Permanent HCPCS Code for Intraoperative Fluorescence Imaging Margin Assessment

  November 20, 2024

   · 

  5 min read
• Press Releases

  Alpha Biopharma received NMPA approval for Zorifertinib Tablets (Zorifer®), the world’s first EGFR-TKI for lung cancer with brain metastases.

  November 20, 2024

   · 

  5 min read
• Press Releases

  Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

  November 20, 2024

   · 

  6 min read
• Press Releases

  enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium

  November 20, 2024

   · 

  7 min read
• Press Releases

  First Patient Dosed in Aptevo’s Ongoing RAINIER Trial Achieves 90% Reduction in Leukemic Blasts Within the First 30 Days of Treatment, Continues Overall Efficacy Trend Seen in Prior Mipletamig AML Studies

  November 20, 2024

   · 

  9 min read
• Press Releases

  Pivot Bio Names Jason Hoag Head of North American Commercial Distribution

  November 20, 2024

   · 

  2 min read
• Press Releases

  Novartis ranks first in 2024 Access to Medicine Index

  November 20, 2024

   · 

  6 min read
• Press Releases

  AIM ImmunoTech Announces Publication of Breast Cancer Data from Roswell Park Comprehensive Cancer Center in The Journal for ImmunoTherapy of Cancer

  November 20, 2024

   · 

  4 min read
• Press Releases

  Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing

  November 20, 2024

   · 

  3 min read
• Press Releases

  SpyGlass Pharma Completes Enrollment in Phase I/II Study of its Promising Long-Term Drug Delivery Platform for Glaucoma and Ocular Hypertension

  November 20, 2024

   · 

  2 min read